Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack A Roth

Showing results (21-30 of 352) with videos related to

Pageof 36
Sort By:
Future Oncology (London, England)|March 25, 2006
3p21.3 tumor suppressor cluster: prospects for translational applicationsLin Ji, John D Minna, Jack A Roth
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Drug resistance in lung cancerManish Shanker, David Willcutts, Jack A Roth, et al.
Biochemistry and Biophysics Reports|March 8, 2016
Detection of siRNA-mediated target mRNA cleavage activities in human cells by a novel stem-loop array RT-PCR analysisJing Lin, Kai Xu, Jack A Roth, et al.
Oncogene|April 18, 2002
C-terminus of p53 is required for G(2) arrestSeiichi Nakamura, Yoshihito Gomyo, Jack A Roth, et al.
Thoracic Surgery Clinics|August 13, 2013
Can stereotactic ablative radiotherapy in early stage lung cancers produce comparable success as surgery?Shervin M Shirvani, Joe Y Chang, Jack A Roth
Seminars in Oncology|March 15, 2002
Genetic and immunologic therapies for lung cancerStephen G Swisher, Jack A Roth, David P Carbone
Nature Reviews. Clinical Oncology|December 24, 2009
Surgery: Future directions in multimodality therapy for NSCLCAnne S Tsao, Jack A Roth, Roy S Herbst
The Journal of Thoracic and Cardiovascular Surgery|February 18, 2018
Comparison of outcomes between muscle-sparing thoracotomy and video-assisted thoracic surgery in patients with cT1 N0 M0 lung cancerReza J Mehran, Linda W Martin, Jack A Roth
Cancer Cell|June 28, 2002
Focus on lung cancerJohn D Minna, Jack A Roth, Adi F Gazdar
Current Opinion in Drug Discovery & Development|April 3, 2003
Development of vaccines against self-antigens: the p53 paradigmSunil Chada, Abner Mhashilkar, Jack A Roth, et al.
Pageof 36

Showing results (21-30 of 352) with videos related to

Sort By:
Pageof 36
Future Oncology (London, England)|March 25, 2006
3p21.3 tumor suppressor cluster: prospects for translational applicationsLin Ji, John D Minna, Jack A Roth
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Drug resistance in lung cancerManish Shanker, David Willcutts, Jack A Roth, et al.
Biochemistry and Biophysics Reports|March 8, 2016
Detection of siRNA-mediated target mRNA cleavage activities in human cells by a novel stem-loop array RT-PCR analysisJing Lin, Kai Xu, Jack A Roth, et al.
Oncogene|April 18, 2002
C-terminus of p53 is required for G(2) arrestSeiichi Nakamura, Yoshihito Gomyo, Jack A Roth, et al.
Thoracic Surgery Clinics|August 13, 2013
Can stereotactic ablative radiotherapy in early stage lung cancers produce comparable success as surgery?Shervin M Shirvani, Joe Y Chang, Jack A Roth
Seminars in Oncology|March 15, 2002
Genetic and immunologic therapies for lung cancerStephen G Swisher, Jack A Roth, David P Carbone
Nature Reviews. Clinical Oncology|December 24, 2009
Surgery: Future directions in multimodality therapy for NSCLCAnne S Tsao, Jack A Roth, Roy S Herbst
The Journal of Thoracic and Cardiovascular Surgery|February 18, 2018
Comparison of outcomes between muscle-sparing thoracotomy and video-assisted thoracic surgery in patients with cT1 N0 M0 lung cancerReza J Mehran, Linda W Martin, Jack A Roth
Cancer Cell|June 28, 2002
Focus on lung cancerJohn D Minna, Jack A Roth, Adi F Gazdar
Current Opinion in Drug Discovery & Development|April 3, 2003
Development of vaccines against self-antigens: the p53 paradigmSunil Chada, Abner Mhashilkar, Jack A Roth, et al.
Pageof 36